Bioequivalence and Bioavailability Forum

Subject	Author	Posted	Rep.	last R.	Views
Replicate/Partial Replicate design acceptance criteria linearized form (Howe’s approximation)	rohitkachhadiya	2013-04-19 11:46	1	2013-04-19 12:12	4,421
4way full replicate SAS routine from FDA guidance Merging problems? Merging problems? critbound? critbound?	jag009	2013-04-08 20:18	4	2013-04-10 19:22	5,174
EMA dataset 1 trouble complete (RR) only EMA dataset 1 - programmers trouble Still not exactly sure Still not exactly sure - why My problem(s) More confusion Confusion help	ElMaestro	2013-04-08 20:23	7	2013-04-10 08:51	6,963
SAS Procedure on Partial Replicate (TRR) Study Data Confusing… Confusing… Confusing… Confusing… Confusing… Confusing… Confusing… 2nd opinion 2nd opinion 3rd, 4th opinion 3rd, 4th opinion Beer swaped Beer swaped	jag009	2013-04-02 21:11	13	2013-04-05 15:18	11,465
SABE or Normal BE? FDA: rSABE for NTIDs SABE or Normal BE? Sample size? SABE or Normal BE? SABE or Normal BE? SABE or Normal BE? SABE or Normal BE? SABE or Normal BE? FDA’s example data sets FDA’s example data sets FDA’s example data sets FDA’s example data sets FDA’s example data sets	luvblooms	2013-02-19 05:07	13	2013-02-22 15:33	13,989
Partial replicate study questions RR data only? RR data only? RR data only?	jag009	2013-02-18 15:47	3	2013-02-19 19:37	5,348
BE with 1 not included in CI ? BE with 1 not included in CI ? BE with 1 not included in CI -danish twist BE with 1 not included in CI -danish twist BE with 1 not included in CI -danish twist BE with 1 not included in CI -danish twist EMA widenend ABEL	Coja66	2013-01-16 10:12	6	2013-02-06 08:27	6,907
FDA’s aggregate BE for NTIDs: example 404 URL corrected URL corrected THX! THX! Home stretch Home stretch estimate only a typo in John’s code only a typo in John’s code FDA’s aggregate BE for NTIDs: example Variances from ABE: different model Variances from ABE: different model Variances from ABE: different model Variances from ABE: different model Yep. Almost there. Yep. Almost there. Done Variances from ABE: different model Variances from ABE: different model Variances from ABE: different model Variances from ABE: different model Variances from ABE: different model	Helmut	2013-01-13 15:54	23	2013-01-20 11:58	16,109
Phoenix/WinNonlin 6.2.1: 95% upper bound limit Phoenix/WinNonlin 6.2.1: 95% upper bound limit Phoenix/WinNonlin: get 6.3! Phoenix/WinNonlin: get 6.3!	K2K	2013-01-15 13:18	3	2013-01-16 03:35	6,979
FDA’s RSABE code (lenghty!) FDA’s RSABE code (lenghty!) FDA’s RSABE code (lenghty!)	Helmut	2012-01-03 03:27	2	2013-01-14 20:40	11,906
Partial replicate for USA Overspecified model	balakotu	2013-01-10 08:37	1	2013-01-10 09:24	5,562
Replicate Design: Scaling FDA Maybe – but why? Maybe – but why? Got it. FDA Mixed up FDA Mixed up Maybe – but why? Maybe – but why? Maybe – but why? Potvin (and beyond?) Potvin (and beyond?)	Ben	2012-10-23 11:32	10	2012-11-01 09:17	10,265
SABE - FDA Progesterone draft (April 2010)	jag009	2012-10-26 22:54	1	2012-10-26 21:04	3,299
Ref. vs. Ref. in partial replicate design Ref. vs. Ref. in partial replicate design again Ref. vs. Ref. in partial replicate design Ref. vs. Ref. in partial replicate design Ref. vs. Ref. in partial replicate design R vs. R in partial replicate design R1 vs R2 R1 vs R2 R1 vs R2 R1 vs R2 treatment df Missunderstanding Missunderstanding, crippled EMA crippled method - R peculiarities All is good, just forget ANOVA - you don't need it! Just forget ANOVA. What next? Just forget ANOVA. What next?	d_labes	2012-04-25 15:52	16	2012-10-15 08:04	13,188
SAS error in 3 way ref replicate study SAS error in 3 way ref replicate study SAS error in 3 way ref replicate study FDA's ABE code and partial replicate design Arbitrary (and unjustified) cut-off of r² Anscombe quartet Anscombe quartet in R Anscombe quartet in R Arbitrary (and unjustified) cut-off of r² Predominant half life; exclusions Excluding time points for lambdaZ Analytical variability Answer machine Well done!	AB	2012-05-04 15:13	13	2012-10-09 17:43	16,828